ARCHIVES

Avon Gives $3 Million To Expand CDC’s Screening Program

This article is from The Cancer Letter archive.

Vol. 20 No. 07 | February 18, 1994

Download PDF Visit The Full Archive

Related Articles

Prevention & Control Study Section In DRG Requested By NCI

February 8, 1991

Erbitux Improves Survival In Advanced Colorectal Cancer

November 30, 2007

NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps

March 28, 2003

Decline In Breast Cancer May Be Related to Drop In HT

March 25, 2011

Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge?

October 7, 2005

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985